I found 34 papers that commented on safety, asserting BPC-157 to be safe, well-tolerated, or harmless. Sikirics group has actually claimed that the LD1 dose has not been achieved, essentially asserting that no reasonable quantity of BPC-157 even could be harmful
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
Nasal administration is not well studied, 1 and the difference in effect on B12 levels amongst individuals may be due to the route of administration
Bicette-McCain has treated a growing number of people with bad reactions after visits to med spas or hydration clinics
Research and development by the countrys top biotechnology companies Purity 99.2%: High bioavailability and no risk of side effects Highly bioactive, ensuring that BPC-157 can effectively exert its effects in the body
Data availability The scRNA-Seq data (HRA000425) were downloaded from China National Center for Bioinformation (CNCB)